Initiating Conversations with Patients about Anti-VEGF Agents
Key opinion leaders emphasize important considerations when discussing the safety of anti-VEGF agents with patients and highlight unmet needs in nonproliferative diabetic retinopathy treatments.
Updates in the Management of Non-Proliferative Diabetic Retinopathy
Drs Ehsan Rahimy and Joseph M. Coney analyze the implications of clinical trial data on the management of nonproliferative diabetic retinopathy.
A Review of Clinical Trial Data in Non-Proliferative Diabetic Retinopathy
A panel of experts reviews data on nonproliferative diabetic retinopathy treatments from the PANORAMA, Protocol W, RISE, and RIDE studies.
Non-Proliferative Diabetic Retinopathy: Goals of Therapy
Dr Joseph M. Coney provides insight into the goals of therapy for patients with nonproliferative diabetic retinopathy.
Early Detection of Non-Proliferative Diabetic Retinopathy
Joseph M. Coney, MD, and Ehsan Rahimy, MD, explain the complications of nonproliferative diabetic retinopathy and emphasize the importance of early detection.
An Overview of Diabetic Retinopathy
Drs Ehsan Rahimy and Diana V. Do define diabetic retinopathy and describe the symptoms.
Making Informed Therapy Decisions for Macular Edema
Expert ophthalmologists debate the rationale behind choosing an anti-VEGF inhibitor for patients and the challenges involved in treatment management.
Efficacy and Safety of Anti-VEGF Agents for Macular Edema
Key opinion leaders review the efficacy and safety of available VEGF inhibitors for the treatment of macular edema and explain how effectiveness is evaluated.
Prescribing VEGF Inhibitors for Macular Edema
Experts in retinal diseases provide insight into when to prescribe VEGF inhibitors and the initial conversations with patients about treatment.
Macular Edema Treatment Goals
W. Lloyd Clark, MD, and Diana V. Do, MD, discuss their goals of treatment and the standard of care for macular edema.
An Overview of VEGF Inhibitors
Ehsan Rahimy, MD, and Diana V. Do, MD, explain the role of VEGF inhibitors in treating macular edema.
2 Commerce Drive Cranbury, NJ 08512